Autoři
TANIWALL, Arian, Jan BROZ (203 Česká republika), Michala LUSTIGOVA (203 Česká republika), Juan P GONZALEZ-RIVAS, Geraldo De Albuquerque M A R A N H A O NETO, Iuliia PAVLOVSKA (804 Ukrajina, domácí), Pavlina KROLLOVA (203 Česká republika), Barbora BERKA (203 Česká republika), Ondrej PATEK (203 Česká republika), Lucia FACKOVCOVA (203 Česká republika), Petr HOFFMANN (203 Česká republika), Jana MLICHOVA (203 Česká republika), Ludmila BRUNEROVA (203 Česká republika) a Jana URBANOVA (203 Česká republika)
Vydání
Bratislava Medical Journal - Bratislavské lekárske listy, BRATISLAVA, Univerzita Komenského, 2024, 0006-9248
V originále
BACKGROUND: Hypertension is a leading cause of cardiovascular disease. This review examines the literature on hypertension control in the Czech Republic from 1972 to 2022 addressing limited data on its effectiveness. METHODS: A literature review was conducted covering the period from 1972 to 2022, utilizing MEDLINE (PubMed), Web of Science, and Scopus databases. Articles were selected based on title and abstract evaluations, with full -text reviews performed as needed. Thirteen studies involving 44,990 participants were included in this review. RESULTS: Control rates increased from 2.8% (men) and 5.2% (women) in 1985 to 32.3% (men) and 37.4% (women) from 2015 to 2018. Women showed better blood pressure control. Specialised centres achieved higher success (48%) than general practitioners (18.4%). Diabetic patients had a lower percentage (29.1%) of patients meeting their target values (<130/80 mmHg) compared to non -diabetic patients, who had a higher percentage (60.6%) meeting their target values (<140/90 mmHg). CONCLUSION: Hypertension treatment success rate in the Czech Republic improved significantly over the last 50 years and is currently comparable to that of other European countries with similar healthcare resources. However, it still remains suboptimal and lags behind the countries with the most successful treatment outcomes (Tab. 3, Fig. 1, Ref. 37) . Text in PDF www.elis.sk